CBG vs CBD: What's the Difference?

By Todd Smith, Co-founder of Joy Organics

Scientifically reviewed by Dr. Jill Palko, OB-GYN — Last reviewed: June 2026

CBG and CBD are both non-intoxicating cannabinoids derived from the hemp plant, but they're distinct compounds that work differently in the body, appear in very different concentrations in the plant, and have different bodies of research behind them. The short version: CBD is more abundant, more studied, and widely available at lower cost. CBG is rarer, newer to research, interacts with the body through different mechanisms, and is increasingly being combined with CBD in full-spectrum products.

This guide breaks down exactly how they differ — and why that difference matters when you're choosing a cannabinoid product.

What Are CBG and CBD?

Both CBG (cannabigerol) and CBD (cannabidiol) are phytocannabinoids — naturally occurring compounds produced by the hemp plant that interact with the body's endocannabinoid system (ECS). Neither is intoxicating. Neither will produce the high associated with THC. Both are legal when derived from hemp containing less than 0.3% THC under the 2018 Farm Bill.

Beyond those similarities, they're meaningfully different compounds.

Both CBG (cannabigerol) and CBD (cannabidiol) are phytocannabinoids — natural compounds found in the hemp plant that interact with the body's endocannabinoid system (ECS). Neither is intoxicating nor psychoactive. Neither will produce the high or intoxicating effects associated with THC. Both are federally legal when hemp-derived CBD or CBG products contain less than 0.3% THC under the 2018 Farm Bill.

Beyond those similarities, they're meaningfully different compounds with distinct chemical structures and potential therapeutic benefits, highlighting the key CBG vs CBD difference.

CBD, a major cannabinoid, was isolated in 1940 and has been studied for decades. It's the most abundant cannabinoid in high-CBD hemp strains, typically making up 15–25% of the plant's dry weight. It has a well-established safety profile and is the basis for Epidiolex, the only FDA-approved CBD-based medication (prescribed for certain rare seizure disorders).

CBG, a minor cannabinoid, was isolated in 1964 by the same researcher who identified THC, Raphael Mechoulam. It's present in much lower concentrations in most hemp plants — often less than 1% — because hemp converts CBG (specifically its precursor, CBGA) into other cannabinoids including CBD and THC as the plant matures. This is why CBG is sometimes called the "mother cannabinoid": it's the raw material the plant uses to build everything else.

Why CBG Is Rarer — and More Expensive

Understanding why CBG products cost more per milligram than comparable CBD products comes down to plant biology.

Early in the hemp plant's life, it produces cannabigerolic acid (CBGA), the acidic form and parent molecule of many cannabinoids. As the plant matures, enzymes convert CBGA into the precursor forms of CBD, THC, CBC, and other cannabinoids. By harvest time, the vast majority of CBGA has already been converted — leaving very little CBG remaining in the plant.

To produce CBG-rich extract, cultivators have two options: harvest plants earlier, before most of the CBGA has converted (which reduces overall yield), or selectively breed high-CBG hemp strains that retain more CBGA through maturity. Both approaches require more resources than standard CBD hemp cultivation.

The result is that producing a given amount of CBG extract requires significantly more plant material than producing the same amount of CBD extract. That cost difference is passed on in the price of CBG products. If you see a CBG product priced similarly to a CBD product with the same milligram count, it's worth looking closely at the COA to confirm the CBG content is accurate and to better understand the cannabinoids present, including THC content. This helps ensure you are purchasing a quality product with verified cannabinoid content and legal status.

How CBG and CBD Interact with the Body

This is where the CBG vs CBD difference matters most — and where the case for combining them becomes clearest.

The Endocannabinoid System

Both compounds work through the body's endocannabinoid system (ECS), a signaling network involved in regulating mood, sleep, stress response, appetite, inflammation, and more. The ECS has two primary receptor types: CB1 receptors (concentrated in the brain and central nervous system) and CB2 receptors (found primarily in immune tissue throughout the body, influencing the immune system).

Your body produces its own endocannabinoids — internal compounds that bind to these receptors. Plant-derived cannabinoids like CBD and CBG, which are non-psychoactive cannabinoids, interact with the same system, influencing how the body responds to certain substances and other medications.

How CBD Works

CBD has low direct affinity for both CB1 and CB2 receptors. Rather than binding to them directly, CBD appears to work by modulating the ECS — influencing how other compounds interact with receptors, inhibiting the breakdown of the body's own endocannabinoids, and interacting with a range of non-cannabinoid receptors including serotonin and TRPV1 receptors. It's an indirect but broad-reaching mechanism.

How CBG Works

CBG interacts more directly with CB1 and CB2 receptors, which are part of the endocannabinoid system found throughout the body and brain. Unlike THC — which also binds CB1 receptors but produces intoxication — CBG binds these receptors without causing a high and has a relatively low affinity compared to THC. Some researchers have proposed that CBG may also act as a GABA reuptake inhibitor, a mechanism associated with calming effects, though this has not been confirmed in robust human trials or clinical studies. [1]

Early research and anecdotal evidence also suggest CBG may have more targeted receptor interactions than CBD, which works indirectly by modulating the endocannabinoid system, and this could make it a useful complement in formulations designed to engage the ECS through multiple pathways simultaneously, combining CBG and CBD to potentially enhance the therapeutic potential.

Why This Makes the Case for Full Spectrum

The concept of the entourage effect — the idea that cannabinoids, terpenes, and other hemp compounds may work more effectively together than any single compound in isolation — is the reasoning behind full spectrum products. If CBD and CBG engage the ECS through different mechanisms, a product containing both may offer a more complete interaction than CBD alone. This is why Joy Organics formulates its CBG tincture as a full spectrum product containing CBG, CBD, and trace THC alongside the hemp plant's naturally occurring terpenes.

CBG vs CBD: Key Differences at a Glance

What Research Shows About Each

CBD Research

CBD is among the most studied cannabinoids in human clinical research. Key areas that have been investigated include:

Seizure disorders: The clearest clinical evidence for CBD is in epilepsy. The FDA approved Epidiolex (pharmaceutical-grade CBD) for Dravet syndrome and Lennox-Gastaut syndrome in 2018, based on randomized controlled trials showing significant seizure reduction. [2]

Sleep: Multiple studies have investigated CBD's influence on sleep. A large 2019 case series found that 66.7% of subjects reported improved sleep scores within the first month of CBD use, though scores fluctuated over time. [3]

Stress response and mood balance: CBD's interaction with serotonin receptors (specifically 5-HT1A) has made it a subject of research in the area of stress and mood regulation. Studies in both animal models and small human trials have shown promising results, though large-scale clinical trials are still limited.

Inflammation: CBD's interaction with the ECS and its influence on immune signaling has led to substantial preclinical research on inflammatory conditions. Human evidence is more limited, and the mechanisms are still being established.

CBG Research

CBG research is newer, and most findings come from preclinical studies (animal models and cell cultures). Key areas include:

Neuroprotection: A 2015 study found that CBG acted as a neuroprotectant in a mouse model of Huntington's disease, reducing neuroinflammation and improving motor function. [4]

Antibacterial activity: A 2020 study identified CBG as effective against MRSA (methicillin-resistant Staphylococcus aureus), a notoriously antibiotic-resistant strain of bacteria. [5]

Appetite regulation: A 2016 rodent study found CBG significantly increased appetite and food consumption compared to controls, suggesting potential applications in appetite support. [6]

Eye pressure: Preclinical research has found that cannabinoids, including CBG, may reduce intraocular pressure, relevant to glaucoma research, though human data is lacking.

Important note: The research on both CBD and CBG is ongoing and in many areas still preliminary, with more research needed to provide a better understanding of their pharmacological case and potential health benefits. Neither compound is an FDA-approved treatment for any condition other than the specific seizure disorders covered by Epidiolex (CBD only). None of the research should be interpreted as evidence that these products diagnose, treat, or cure any disease.

Do CBG and CBD Work Better Together?

The short answer from existing research is: possibly, and the reasoning is scientifically plausible, considering the different cannabinoids and their unique interactions with the endocannabinoid system.

The entourage effect hypothesis — originally proposed by Raphael Mechoulam (who isolated both CBG and CBD) — suggests that the compounds found in whole hemp plants, including various cannabis strains and their diverse cannabinoid profiles, work synergistically. Each cannabinoid, terpene, and plant compound contributes to an overall effect that may be greater than the sum of its parts.

For CBD and CBG specifically, the argument is mechanistic: because they engage the ECS through different pathways (CBD indirectly, CBG more directly at the receptor level), a combination may produce a more complete and nuanced interaction with the endocannabinoid system than either alone.

There's also a practical consideration. Because CBG is costly to produce at high concentrations, most CBG products contain CBG alongside CBD rather than as a pure isolate. This makes full spectrum or broad spectrum CBG+CBD products the most common format in the market.

Joy Organics' CBG tincture is full spectrum, meaning it contains CBG, CBD, trace amounts of THC (federally legal amount, under 0.3%), and the hemp plant's naturally occurring terpenes — formulated to preserve the entourage effect, the positive effects of combining two cannabinoids, rather than strip out any single component.

Shop Joy Organics Organic CBG Tincture →

How to Choose: CBG, CBD, or Both?

The right choice depends on what you're looking for and where you are in your experience with cannabinoids.

Start with CBD if: You're new to cannabinoids. CBD has a longer research history, is more widely available, and is better understood in terms of its safety profile and mechanism. It's a lower-cost starting point with more product variety and options to consume it through oils, edibles, or vapes.

Add or switch to CBG if: You've used CBD and want to explore the broader cannabinoid spectrum, or you're specifically curious about CBG's distinct receptor interactions. A CBG+CBD product is a logical next step.

Use both together if: You want the most complete hemp extract experience. A full-spectrum product that prominently features CBG alongside CBD gives you the benefits of both compounds plus the potential entourage effect of the full plant.

Consider isolate if: You have a specific reason to avoid other cannabinoids — for example, if you're subject to drug testing that could flag trace THC, or if you want to isolate one variable in your routine. Both CBD isolate and CBG isolate are available, though you give up the entourage benefit.

What to Look for in a CBG or CBD Product

Whether you're buying CBG, CBD, or a combination, the quality evaluation criteria are the same.

Certificate of Analysis (COA)

This is the most important thing to verify. A COA is a report from an independent third-party laboratory confirming what's actually in the product — cannabinoid potency, contaminant screening (pesticides, heavy metals, residual solvents, microbials), and potential contaminants affecting overall health. A trustworthy brand makes COAs easy to find, ideally with a QR code on the packaging that links directly to the current batch result.

For a CBG product specifically, the COA should clearly show CBG content per serving. If the COA only shows CBD and THC levels, the product likely contains negligible amounts of CBG regardless of what the label implies.

Joy Organics publishes batch-specific COAs for all products. View our lab results →

USDA Organic Certification

Hemp absorbs compounds from its growing environment, including pesticides, herbicides, and heavy metals from the soil. USDA-certified organic hemp is grown under federally regulated standards that prohibit synthetic pesticides and fertilizers. This is particularly relevant for full spectrum products, where the goal is to preserve the plant's full chemical profile — including anything it may have absorbed during growth.

Joy Organics is USDA-certified organic — one of a relatively small number of CBD/CBG brands with this certification.

Milligrams of Each Cannabinoid

Read the label carefully. A product marketed as a "CBG tincture" should clearly state CBG mg per serving, not just total cannabinoids. If the label shows 1000mg total cannabinoids but doesn't break out how much is CBG, treat that as a red flag. The COA should answer the question the label leaves open.

Spectrum Type

As covered above: full spectrum retains THC (under 0.3%), broad spectrum removes THC, isolate contains one cannabinoid only. Your choice depends on your goals and any constraints around THC sensitivity.

Frequently Asked Questions

Is CBG the same as CBD?

No. CBG (cannabigerol) and CBD (cannabidiol) are distinct compounds with different molecular structures, different receptor interactions, different research histories, and different concentrations in the hemp plant. Both are non-intoxicating hemp-derived cannabinoids, but they work through different mechanisms.

Is CBG stronger than CBD?

"Stronger" isn't quite the right frame. CBG binds more directly to CB1 and CB2 cannabinoid receptors than CBD does, but this doesn't make it more potent in a general sense — it means it acts differently. CBD has a broader research base and more established applications, with a longer history of study regarding CBD effects. CBG research is newer and explores different areas. Many people use both together rather than choosing one.

What is the difference between CBD and CBG?

The main differences are: origin in the plant (CBG is the precursor that converts into CBD and other cannabinoids), abundance (CBD is far more plentiful in mature hemp plant), cost (CBG is more expensive per mg to produce), receptor interaction (CBD works indirectly on the ECS; CBG binds CB1 and CB2 more directly), and research maturity (CBD has decades of research; CBG is in early stages).

Can you take CBG and CBD together?

Yes. Many full spectrum hemp products contain both, and the entourage effect hypothesis suggests they may complement each other. There are no known safety concerns with using CBG and CBD together, though you should consult a healthcare provider if you take prescription medications for chronic pain, anxiety disorders, or anti-inflammation, as both cannabinoids may interact with drugs processed by CYP450 liver enzymes, which can affect brain health and overall metabolism.

Will CBG or CBD make you fail a drug test?

Pure CBD isolate and pure CBG isolate are less likely to cause a positive drug test than full spectrum products, which contain trace amounts of THC (under 0.3%). However, trace THC can accumulate with regular use, and some tests are sensitive enough to detect it. If you are subject to drug testing, consult your employer or testing guidelines before using any hemp-derived product.

Does CBG give you energy?

CBG is non-intoxicating cannabinoid native to the cannabis plant and doesn't produce a stimulant effect in the way caffeine does. Some users report feeling more focused or alert after taking CBG, particularly in morning routines, but this is based on anecdotal experience rather than clinical evidence. CBG does not contain caffeine or any stimulant compounds.

Which is better for sleep, CBG or CBD?

Sleep research has focused more on CBD than CBG. CBG's appetite-stimulating effects in rodent studies are sometimes cited as a reason it may be better suited to daytime use, though this has not been confirmed in humans. For sleep, CBD — particularly in combination with CBN (another cannabinoid studied for its potential relaxation effects) — has more supporting evidence. See Joy Organics' CBD Sleep Gummies with CBN →

The Bottom Line

CBG and CBD are not competitors — they're complementary compounds that engage the body's endocannabinoid system through different mechanisms. CBD has a longer research history and wider availability. CBG is rarer, costs more to produce, and is the subject of growing scientific interest for its distinct receptor interactions. A full spectrum product that combines both gives you the broadest possible engagement with the hemp plant's cannabinoid profile.

Whatever you choose, the quality of the product matters as much as the milligrams on the label. Verify the COA, look for USDA organic certification, and confirm that the cannabinoid content is clearly stated per serving — not just per bottle.

Explore Joy Organics' organic full-spectrum CBG tincture →

Learn more: What Is CBG? Complete Guide →

See how CBG compares to CBN →

These statements have not been evaluated by the Food and Drug Administration. CBD and CBG products are not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare provider before adding any new supplement to your routine, particularly if you are pregnant, nursing, or taking prescription medications.

Sources

1. Cascio MG, et al. "Evidence That the Plant Cannabinoid Cannabigerol Is a Highly Potent Alpha-2-Adrenoceptor Agonist and Moderately Potent 5HT1A Receptor Antagonist." British Journal of Pharmacology. 2010;159(1):129–141. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823359/

2. Devinsky O, et al. "Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome." New England Journal of Medicine. 2017;376(21):2011–2020. https://www.nejm.org/doi/full/10.1056/NEJMoa1611618

3. Shannon S, et al. "Cannabidiol in Anxiety and Sleep: A Large Case Series." The Permanente Journal. 2019;23:18–041. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326553/

4. Valdeolivas S, et al. "Neuroprotective Properties of Cannabigerol in Huntington's Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice." Neurotherapeutics. 2015;12(1):185–199. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322067/

5. Farha MA, et al. "Uncovering the Hidden Antibiotic Potential of Cannabis." ACS Infectious Diseases. 2020;6(3):338–346. https://pubs.acs.org/doi/10.1021/acsinfecdis.9b00419

6. Brierley DI, et al. "Cannabigerol is a Novel, Well-Tolerated Appetite Stimulant in Pre-Satiated Rats." Psychopharmacology. 2016;233(19-20):3603–3613. https://pubmed.ncbi.nlm.nih.gov/27563840/